Teva to pay more than $7 billion for US Barr Pharmaceuticals

for more than $7 billion, in a move to expand its presence in US and Eastern European markets.

Teva Pharmaceutical Industries Ltd. Also is offering to assume $1.5 billion of Montvale, New Jersey-based Barr Pharmaceuticals Inc.'s debt. (AP)